Mayne Pharma reported AUD1.22B in Ordinary Share Capital for its fiscal semester ending in June of 2024.


Ordinary Share Capital Change Date
Ansell USD 1.03B 305.2M Jun/2024
Cochlear AUD 1.18B 19.2M Dec/2024
CSL USD 576M 19M Dec/2024
Healius AUD 2.6B 100K Dec/2024
Integral Diagnostics AUD 335.09M 1.07M Jun/2024
Medical Developments International AUD 115.01M 9.28M Dec/2024
Nanosonics AUD 114.74M 192K Dec/2024
Next Science USD 133.93M 100.99K Dec/2024
Polynovo AUD 191.6M 0 Jun/2024
Ramsay Health Care AUD 2.27B 19.6M Dec/2024
ResMed USD 146.39M 145.63M Jun/2025
Sigma Healthcare AUD 1.64B 43.99M Jul/2024
Sonic Healthcare AUD 4.15B 467K Dec/2024
Telix Pharmaceuticals AUD 334.72M 252.68M Dec/2024